Published in Thorax on March 01, 2001
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child (2002) 3.35
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child (2006) 1.43
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease. Br J Clin Pharmacol (2003) 1.36
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease. Ann Thorac Med (2012) 1.10
Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma. Br J Clin Pharmacol (2006) 0.98
Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.91
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Respir Res (2004) 0.86
From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids. Int J Gen Med (2013) 0.82
Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. Thorax (2002) 0.82
Difficult asthma in children. Thorax (2002) 0.80
The role of inhaled corticosteroids in the management of cystic fibrosis. Paediatr Drugs (2009) 0.80
Inhaled Corticosteroids. Pharmaceuticals (Basel) (2010) 0.79
Systemic effects of inhaled corticosteroids are milder in asthmatic patients than in normal subjects. Thorax (2001) 0.78
Systemic effects of inhaled steroids. Thorax (2001) 0.75
Systemic effects of inhaled steroids. Thorax (2001) 0.75
Rapid method for measurement of bronchial responsiveness. Thorax (1983) 7.06
Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet (2000) 4.22
Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis (1993) 2.97
Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax (1993) 2.81
Adrenal function in asthma. Arch Dis Child (1990) 2.29
Inhaled corticosteroids: benefits and risks. Thorax (1992) 2.17
Molecular mechanisms of glucocorticoid action: what is important? Thorax (2000) 2.16
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J (1993) 1.84
Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax (1996) 1.77
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax (1997) 1.43
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J (1995) 1.35
Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J (1996) 1.34
Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study. Am J Respir Crit Care Med (1997) 1.28
Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Chest (1999) 1.23
Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab (1991) 1.21
High dose inhaled corticosteroids and dose dependent loss of diabetic control. BMJ (1998) 1.17
Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med (1998) 1.15
Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol (1991) 1.10
A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Eur J Clin Pharmacol (1997) 1.03
Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults. Br J Clin Pharmacol (1999) 0.89
Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults. J Allergy Clin Immunol (1998) 0.86
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet (1988) 4.85
Asthma, wheezing, and school absence in primary schools. Arch Dis Child (1989) 4.57
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med (1969) 2.99
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet (1990) 2.31
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Assessment and management of asthma in an accident and emergency department. Thorax (1985) 2.21
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19
Sudden death in asthma: discussion paper. J R Soc Med (1983) 2.13
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
Bronchoprotective role for endogenous prostaglandin E2. Lancet (1995) 2.01
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85
Management of asthma in schools. Arch Dis Child (1987) 1.81
Clinical experience of lymphangioleiomyomatosis in the UK. Thorax (2000) 1.80
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis (1992) 1.73
Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet (1994) 1.71
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis (1989) 1.66
How patients use domiciliary oxygen. Br Med J (1978) 1.66
Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1979) 1.65
Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax (1983) 1.64
Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J (1993) 1.61
Dosage and delivery of nebulised beta agonists in hospital. Thorax (1983) 1.59
Attitudes and long-term adjustment of patients surviving cardiac arrest. Br Med J (1971) 1.57
Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis (1984) 1.52
Step 3 of the asthma guidelines. Thorax (1999) 1.48
Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46
Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology (1999) 1.42
Guillain-Barre syndrome associated with Campylobacter infection. Br Med J (Clin Res Ed) (1982) 1.42
Bronchodilator drugs. Pharmacol Ther (1982) 1.39
Abnormal urinary steroid profiles in four hypertensive obese children. J Pediatr Endocrinol Metab (2010) 1.39
Asthma induced by suggestion: is it due to airway cooling? Am Rev Respir Dis (1984) 1.38
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax (2001) 1.38
Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis (1993) 1.37
Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33
Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax (2004) 1.32
Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax (1988) 1.32
Assessment of bronchial beta blockade after oral bevantolol. Clin Pharmacol Ther (1981) 1.32
Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis (1991) 1.30
High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis (1988) 1.30
Assessing change in airway calibre--measurement of airway resistance. Br J Clin Pharmacol (1979) 1.29
A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects. Eur Respir J (1991) 1.26
Measurement of bronchial reactivity: a question of interpretation. Thorax (1981) 1.25
Left ventricular pressures in two patients with myocardial infarction. Lancet (1968) 1.24
Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ (1997) 1.20
Effects of beta-adrenergic blockade and stimulation on normal human airways. J Appl Physiol (1973) 1.19
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J (1994) 1.17
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax (2006) 1.15
Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax (1992) 1.14
Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis (1993) 1.13
Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Health Care (2009) 1.10
Reduced respiratory responses to carbon dioxide after propranolol: a central action. Br Med J (1976) 1.09
Coeliac disease and HLA-DQ 2 (DQA1* 0501 and DQB1* 0201) in patients with Turner syndrome. J Pediatr Gastroenterol Nutr (2001) 1.08
Age effects on executive ability. Neuropsychology (2000) 1.08
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax (2000) 1.06
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol. Br J Clin Pharmacol (1981) 1.06
Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax (1988) 1.05
Morbidity from asthma in relation to regular treatment: a community based study. Thorax (1999) 1.05
Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.04
A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis (1991) 1.04
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J (1999) 1.03
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax (1997) 1.02
Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril (1990) 1.01
Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study. Thorax (1994) 1.01
Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax (1991) 1.01
Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J Endocrinol Invest (2009) 1.00
Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol Med Microbiol (1995) 0.99
Chest x-ray film in acute myocardial infarction. Br Med J (1969) 0.99
Central nervous system manifestations of hyperparathyroidism. Am J Med (1978) 0.97
Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med (1994) 0.97
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax (2004) 0.97
Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man. Br J Clin Pharmacol (1983) 0.96
Does measurement of bronchial hyperreactivity help in the clinical diagnosis of asthma? Eur J Respir Dis (1986) 0.96
Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax (1994) 0.95
Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol (1984) 0.93
Who should look after asthma? Thorax (1995) 0.92
Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM (2011) 0.92
Tolerance to beta-agonists. Bull Eur Physiopathol Respir (1986) 0.92
Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax (1991) 0.92
Changes in lung mechanics during asthma induced by exercise. J Appl Physiol (1975) 0.92
Action of intravenously administered aminophylline on normal airways. Am Rev Respir Dis (1983) 0.91